Gordon Reid Kendle International Inc. KNDL-Q PAST TOP PICK Nov 11, 2009

(A Top Pick Nov 8/12. Down 10%.) Contract research. Lost confidence in management.

Gordon Reid

Unlock Rating

$17.030

Stock price when the opinion was issued

medical services

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

Clinical research organization that does drug trials phase 1 through 4. They manage the regulatory side of the trial. Has been a very successful company. Stumbled a little bit on one-time costs and is trading below its peer group and its own historical multiples.

TOP PICK

Contract research organization. They basically take outsourced trials from pharmaceutical companies and do the phase 1 through 4 trials. Fits well into the time we are in where everyone wants to save money in health care. Trading at about 7.5X earnings. Recent earnings were very good.

PAST TOP PICK

(A Top Pick May 14/08. Down 74%.)

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Gordon Reid Kendle International Inc. KNDL-Q PAST TOP PICK Nov 11, 2009

You might be interested:

Kendle International Inc.(KNDL-Q)

Kendle International Inc.(KNDL-Q)

Kendle International Inc.(KNDL-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights